X
Market Data
$60.42−$5.00 (−7.64%)
XENE · Last trade
Prev Close
$65.42
Range (29d)
$59.73 – $65.78
Recent Filings
- 1445.2 KBXenon Pharmaceuticals Inc.Aug 13, 4:30 PM ET·0001193125-26-349336
- SCHEDULE 13G/A15.4 KBXenon Pharmaceuticals Inc.Aug 13, 4:08 PM ET·0000902219-26-000248
- SCHEDULE 13G/A11.7 KBXenon Pharmaceuticals Inc.Aug 7, 11:04 AM ET·0000315066-26-002245
- 10-Q10.2 MBXenon Pharmaceuticals Inc.Aug 6, 4:31 PM ET·0001193125-26-338244
- 8-K464.4 KBXenon Pharmaceuticals Inc.Aug 6, 4:11 PM ET·0001193125-26-338019
- SCHEDULE 13G/A11.7 KBXenon Pharmaceuticals Inc.Aug 6, 10:43 AM ET·0000315066-26-002171
- 8-K971.2 KBXenon Pharmaceuticals Inc.Jun 3, 4:02 PM ET·0001193125-26-255396
- 10-Q8.9 MBXenon Pharmaceuticals Inc.May 7, 4:35 PM ET·0001193125-26-212153
- 8-K380.2 KBXenon Pharmaceuticals Inc.May 7, 4:02 PM ET·0001193125-26-211843
- 8-K742.6 KBXenon Pharmaceuticals Inc.Apr 13, 4:01 PM ET·0001193125-26-152834
Insiders
10- AULIN SHERRYChief Financial Officer
- AYCARDI-FONSECA ERNESTOCMO
- AZAB MOHAMMADDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Bridger GaryEVP, Research & Development
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- Cannon GillianDirector
Tickers
Addresses
business
200 - 3650 GILMORE WAY
BURNABY
mailing
200 - 3650 GILMORE WAY
BURNABY